18.02.2013
- Novozymes acquires Iogen Bio-Products, industrial enzyme business of Ottawa-based Iogen Corporation for CAD 67.5 million (approximately DKK 370 million) and potential earn-out...
12.02.2013
- Novozymes Biopharma today announced a collaborative research agreement with Rhode Island-based biotech company EpiVax, to help further the development of a treatment for autoimmune...
21.01.2013
- Danish industrial enzymes maker Novozymes said it aims to keep margins at the current high level over the next five years through production efficiency measures, helping send its...
07.12.2012
- Makers of chemicals and plastics from plant matter are emerging as unlikely beneficiaries of the abundance of U.S. shale gas, which is shaking up the global petrochemical industry...
17.08.2012
- Novozymes has developed a fungus that enables production of malic acid from renewable raw materials instead of oil. Malic acid is used as a flavor enhancer in the food industry and...
14.06.2012
- Modern Excipients - Traditionally, excipients have never received the same attention as that given to the Active Pharmaceutical ingredient (API). Instead they have been seen as...
09.05.2012
- Novozymes Biopharma, part of Novozymes, has announced the first shipment of the company's Bacillus-derived hyaluronic acid, Hyasis, from its newly inaugurated manufacturing...
25.04.2012
- Syngenta and Novozymes announced a global agreement under which Syngenta will work with Novozymes to commercialize the Novozymes technology JumpStart, a seed-applied biological...
